Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis

Nuhoho, S; Gupta, J; Hansen, BB; Fletcher-Louis, M; Tam, DT; Paine, A

Nuhoho, S (reprint author), Novo Nordisk AS, Soborg, Denmark.

DIABETES THERAPY, 2019; 10 (6): 2183

Abstract

Introduction Orally administered semaglutide is the first glucagon-like peptide 1 receptor agonist (GLP-1 RA) for oral administration. As head-to-head......

Full Text Link